Using enho gene therapy to treat cardiometabolic disease
US-2026091136-A1 · Apr 2, 2026 · US
This page is not indexed by search engines while we improve data quality.
Univ Pittsburgh Commonwealth Sys Higher Education — Human Necessities
Univ Pittsburgh Commonwealth Sys Higher Education holds 1,026 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Univ Pittsburgh Commonwealth Sys Higher Education |
| Technology | Human Necessities |
| Patents in slice | 1,026 |
| Recent patents in slice | 345 |
| First year | 2017 |
| Last year | 2026 |
Representative patents
Notable publications linking Univ Pittsburgh Commonwealth Sys Higher Education to Human Necessities.
Using enho gene therapy to treat cardiometabolic disease
US-2026091136-A1 · Apr 2, 2026 · US
Using enho gene therapy to treat cardiometabolic disease
US-2026091136-A1 · Apr 2, 2026 · US
Using enho gene therapy to treat cardiometabolic disease
US-2026091136-A1 · Apr 2, 2026 · US
Using enho gene therapy to treat cardiometabolic disease
US-2026091136-A1 · Apr 2, 2026 · US
Recent filings
Latest patents from Univ Pittsburgh Commonwealth Sys Higher Education in Human Necessities.
Using enho gene therapy to treat cardiometabolic disease
US-2026091136-A1 · Apr 2, 2026 · US
Using enho gene therapy to treat cardiometabolic disease
US-2026091136-A1 · Apr 2, 2026 · US
Using enho gene therapy to treat cardiometabolic disease
US-2026091136-A1 · Apr 2, 2026 · US
Using enho gene therapy to treat cardiometabolic disease
US-2026091136-A1 · Apr 2, 2026 · US
Using enho gene therapy to treat cardiometabolic disease
US-2026091136-A1 · Apr 2, 2026 · US
Related pages
Navigate to parent entity pages.